Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieuwe Appel

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 19, 2013
Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PETLieuwe Appel, Mats Bergström, Jørgen Buus Lassen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2009
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humansLieuwe Appel, Yona Geffen, Kerstin Heurling, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 17, 2026
Non-invasive modelling and parametric methods for quantification of MAO-B activity using [<sup>11</sup>C]L-deprenyl-D2 PETKarolina Hedman, My Jonasson, Lieuwe Appel, et al.
European Journal of Clinical Pharmacology|August 10, 2006
Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differencesStina Syvänen, Gunnar Blomquist, Lieuwe Appel, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 2, 2023
Comparison of quantitative [<sup>11</sup>C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET systemJoão M Sousa, Lieuwe Appel, Mathias Engström, et al.
Biological Psychiatry|September 5, 2006
Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor systemAsa Michelgård, Lieuwe Appel, Anna Pissiota, et al.
Psychiatry Research|March 27, 2009
Disentangling the web of fear: amygdala reactivity and functional connectivity in spider and snake phobiaFredrik Ahs, Anna Pissiota, Asa Michelgård, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
Use of 11C-PE2I PET in differential diagnosis of parkinsonian disordersLieuwe Appel, My Jonasson, Torsten Danfors, et al.
Plos One|May 5, 2011
Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammationClas Linnman, Lieuwe Appel, Mats Fredrikson, et al.
Psychopharmacology|August 10, 2025
Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-humanLieuwe Appel, Robert Risinger, Anders Wall, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 19, 2013
Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PETLieuwe Appel, Mats Bergström, Jørgen Buus Lassen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2009
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humansLieuwe Appel, Yona Geffen, Kerstin Heurling, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 17, 2026
Non-invasive modelling and parametric methods for quantification of MAO-B activity using [<sup>11</sup>C]L-deprenyl-D2 PETKarolina Hedman, My Jonasson, Lieuwe Appel, et al.
European Journal of Clinical Pharmacology|August 10, 2006
Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differencesStina Syvänen, Gunnar Blomquist, Lieuwe Appel, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 2, 2023
Comparison of quantitative [<sup>11</sup>C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET systemJoão M Sousa, Lieuwe Appel, Mathias Engström, et al.
Biological Psychiatry|September 5, 2006
Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor systemAsa Michelgård, Lieuwe Appel, Anna Pissiota, et al.
Psychiatry Research|March 27, 2009
Disentangling the web of fear: amygdala reactivity and functional connectivity in spider and snake phobiaFredrik Ahs, Anna Pissiota, Asa Michelgård, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
Use of 11C-PE2I PET in differential diagnosis of parkinsonian disordersLieuwe Appel, My Jonasson, Torsten Danfors, et al.
Plos One|May 5, 2011
Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammationClas Linnman, Lieuwe Appel, Mats Fredrikson, et al.
Psychopharmacology|August 10, 2025
Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-humanLieuwe Appel, Robert Risinger, Anders Wall, et al.
Pageof 5